Immatics Management
Management criteria checks 3/4
Immatics' CEO is Harpreet Singh, appointed in Jul 2019, has a tenure of 5.33 years. total yearly compensation is €6.38M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 1.07% of the company’s shares, worth €9.25M. The average tenure of the management team and the board of directors is 4.3 years and 3.5 years respectively.
Key information
Harpreet Singh
Chief executive officer
€6.4m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 5.3yrs |
| CEO ownership | 1.1% |
| Management average tenure | 4.3yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€56m |
| Jun 30 2024 | n/a | n/a | -€74m |
| Mar 31 2024 | n/a | n/a | -€80m |
| Dec 31 2023 | €6m | €488k | -€97m |
| Sep 30 2023 | n/a | n/a | -€84m |
| Jun 30 2023 | n/a | n/a | -€79m |
| Mar 31 2023 | n/a | n/a | -€68m |
| Dec 31 2022 | €7m | €522k | €38m |
Compensation vs Market: Harpreet's total compensation ($USD6.69M) is above average for companies of similar size in the German market ($USD1.44M).
Compensation vs Earnings: Harpreet's compensation has been consistent with company performance over the past year.
CEO
Harpreet Singh (49 yo)
5.3yrs
Tenure
€6,378,000
Compensation
Dr. Harpreet Singh, Ph D., has been Non-Executive Director of Immatics N.V. since July 1, 2021 and served as its Supervisory Director since 2021 until July 1, 2021. Dr. Singh serves as Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 5.3yrs | €6.38m | 1.07% € 9.2m | |
| Co-Founder & Chief Innovation Officer | 24.8yrs | no data | 0.27% € 2.3m | |
| Chief Financial Officer | 4.1yrs | no data | 0.14% € 1.2m | |
| Chief Operations Officer | 1.7yrs | no data | 0.23% € 2.0m | |
| General Counsel & Secretary | 4.3yrs | no data | 0.090% € 773.8k | |
| Chief Development Officer | 5.1yrs | no data | 0.39% € 3.3m | |
| Chief Medical Officer | 4.4yrs | no data | 0.19% € 1.6m | |
| Head of Strategy | no data | no data | 0.16% € 1.4m | |
| Co-Founder & Member of the Scientific Advisory Board | 24.8yrs | no data | no data | |
| Vice President of SEC Reporting & Accounting | less than a year | no data | no data | |
| Vice President of Marketing | less than a year | no data | no data | |
| VP of Human Resources & US Site Head | 2.3yrs | no data | no data |
4.3yrs
Average Tenure
49yo
Average Age
Experienced Management: 4A3's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 3.3yrs | €6.38m | 1.07% € 9.2m | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | €263.00k | 0.046% € 400.5k | |
| Non-Executive Chairman | 3.3yrs | €283.00k | 0.31% € 2.7m | |
| Independent Vice Chair of the Board of Directors | 3.3yrs | €246.00k | 0.046% € 400.5k | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 3.7yrs | no data | no data | |
| Independent Non-Executive Director | 3.3yrs | €259.00k | 0.046% € 400.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.8yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 4.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data |
3.5yrs
Average Tenure
63yo
Average Age
Experienced Board: 4A3's board of directors are considered experienced (3.5 years average tenure).